Kopran Share Price

Small Cap | Pharmaceuticals and health care | NSE: KOPRAN | BSE: 524280

₹160.75 image2.50 (1.58 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 161.20

High (₹) 163.10

Low (₹) 157.10

Prev. Close (₹) 158.25

Volume 41,577

VWAP (₹) 169.62

ROCE (%) 14.51

Industry P/E 43.95

TTM P/E 16.34

P/B Ratio 1.58

Market Cap (₹) Cr.776.00

Dividend Yield (%)1.87

EPS (₹) 10.57

ROE10.37%

Sales Growth (%) 11.54

Profit Growth (%)87.11

Day Range

163.10163.10

L
H

52 Week Range

157.10369.20

L
H

Historical Returns

Returns (6M)

-53.99 %

Returns (1Y)

-37.91 %

Returns (3Y)

-44.89 %

Returns (5Y)

689.93 %

Returns (6M)

-53.99 %

Returns (1Y)

-37.91 %

Returns (3Y)

-44.89 %

Returns (5Y)

689.93 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (87.08%) TTM EPS Growth
  • Company with Low Debt
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
  • Company with 87.08% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Growth in Net Profit Margin (QoQ)
  • Bullish MACD crossover (12,6,9) indicates potential upward price movement.
  • Positive ROC (9) indicates upward momentum.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 39.90

MFI 71.61

ATR 9.94

Commodity Channel Index -95.04

ROC125 -43.23

ROC21 -9.89

Williams %R -77.27

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current174.79180.57184.34171.02165.24161.47155.69
Week Ago191.70197.65202.50186.85180.90176.05170.10
Month Ago191.56199.33204.01186.88179.11174.43166.66

EMA & SMA
info_icon

160.75

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 181.72


9 Day 177.13


10 Day 174.52


12 Day 175.23


14 Day 176.51

20 Day 178.56


26 Day 182.06


50 Day 195.53


100 Day 228.70


200 Day 251.44

Deals & Announcements

Bulk and Block Deals

No bulk or block deals available.

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
08 Jan, 2025Mridula SomaniAcquisition17,64,750BSE
20 Dec, 2024Mridula SomaniAcquisition17,64,750BSE
05 Jun, 2023Mridula SomaniAcquisition₹10.002,89,000BSE
03 Apr, 2023Surendra SomaniAcquisition₹107.9328,500BSE
03 Apr, 2023Surendra SomaniAcquisition₹107.0865,500BSE
30 Jan, 2023Mridula SomaniAcquisition2,70,500BSE
22 Nov, 2022HAZARIMALL SOMANIAcquisition₹135.0611,000BSE
17 Nov, 2022HAZARIMALL SOMANIAcquisition₹149.2010,000BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
16 May, 2024Rs.3.0000 per share(30%)Final Dividend02 Sept, 202401 Jan, 1970
25 May, 2023Rs.3.0000 per share(30%)Dividend07 Sept, 202301 Jan, 1970
27 May, 2022Rs.3.0000 per share(30%)Final Dividend04 Aug, 202201 Jan, 1970

Announcements

DateSourceDetail
10 Mar, 2025NSE IndiaThe Exchange has sought clarification from Kopran Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. The response of the Company is awaited.
27 Feb, 2025NSE IndiaKopran Limited has informed the Exchange about Issue of Duplicate Share Certificate
27 Feb, 2025NSE IndiaKOPRAN LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation
17 Feb, 2025BSE IndiaTranscript and Recording for Earning Q3 FY 2024-25
17 Feb, 2025BSE IndiaTranscript for Earning Q3 FY 2024-25
17 Feb, 2025NSE IndiaKopran Limited has informed the Exchange about Transcript and Link of Recording
13 Feb, 2025BSE IndiaIntegrated filing for Q3 2025 financial results
13 Feb, 2025NSE IndiaKopran Limited has informed the Exchange about Copy of Newspaper Publication
13 Feb, 2025NSE IndiaIntegrated filing of Q3 Fy 2025 Financial results
11 Feb, 2025BSE IndiaInvestor Presentation for Financial Result Q3 FY 2024-25

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--05 Feb, 202511 Feb, 2025
Quarterly Results--06 Nov, 202413 Nov, 2024
Quarterly Results--24 Jul, 202408 Aug, 2024
Audited Results & Final Dividend--10 May, 202416 May, 2024
Quarterly Results--24 Jan, 202407 Feb, 2024
Quarterly Results--27 Oct, 202307 Nov, 2023
Quarterly Results--02 Aug, 202310 Aug, 2023
Audited Results & Dividend--17 May, 202325 May, 2023
Quarterly Results--30 Jan, 202310 Feb, 2023
Quarterly Results--02 Nov, 202211 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Kopran

Kopran is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 337.46 Cr. and Equity Capital is Rs. 48.21 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Parijat Group

Founded

1958

Managing Director

-- --

NSE Symbol

KOPRAN

Kopran Management

NameDesignation
Mr. Susheel G SomaniChairman
Mr. Surendra SomaniExecutive Vice Chairman
Mr. Adarsh SomaniDirector
Mr. Varun SomaniDirector
Dr. Siddhan SubramanianIndependent Director
Dr. Sunita BanerjiIndependent Director
Mrs. Mamta BiyaniIndependent Director
Mr. Narayan AtalIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Kopran

What is the share price of Kopran?

The share price of Kopran on 13 Mar, 2025 is ₹ 160.75.

What is 52W high and 52W low share price of Kopran?

The highest and lowest 52W share prices of Kopran are ₹ 369.200 and ₹ 157.100

What is the market cap of Kopran?

The market capitalization of Kopran as of 13 Mar, 2025 is ₹ 776.00 Crores

What is the P/E ratio of Kopran?

The current P/E ratio of Kopran as of 13 Mar, 2025 is 43.95

What is the PB ratio of Kopran?

The PB ratio of Kopran as of 13 Mar, 2025 is 1.58

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited